Part 1 - Highlights of the San Antonio Breast Cancer Symposium 2023.
作者信息
Benson John R, Jatoi Ismail
机构信息
Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust & School of Medicine, Anglia Ruskin University, Cambridge, UK.
Division of Surgical Oncology, Dale H. Dorn Chair in Surgery, University of Texas Health Science Centre, San Antonio, TX 78240, USA.
出版信息
Future Oncol. 2024 Dec;20(40):3343-3345. doi: 10.1080/14796694.2024.2418804. Epub 2024 Oct 29.
Abstract
摘要
相似文献
1
Part 1 - Highlights of the San Antonio Breast Cancer Symposium 2023.第一部分 - 2023年圣安东尼奥乳腺癌研讨会亮点
Future Oncol. 2024 Dec;20(40):3343-3345. doi: 10.1080/14796694.2024.2418804. Epub 2024 Oct 29.
2
Part 2 - Highlights of the San Antonio Breast Cancer Symposium 2023.第二部分 - 2023年圣安东尼奥乳腺癌研讨会亮点
Future Oncol. 2024 Dec;20(40):3347-3350. doi: 10.1080/14796694.2024.2418797. Epub 2024 Oct 29.
3
Highlights of the San Antonio Breast Cancer Symposium 2015: part 2.2015年圣安东尼奥乳腺癌研讨会亮点：第二部分。
Future Oncol. 2016 Apr;12(7):897-900. doi: 10.2217/fon-2016-0044. Epub 2016 Feb 15.
4
Highlights of the San Antonio Breast Cancer Symposium 2015: part 1.2015年圣安东尼奥乳腺癌研讨会亮点：第一部分。
Future Oncol. 2016 Apr;12(7):893-6. doi: 10.2217/fon-2016-0043. Epub 2016 Feb 15.
5
Tailoring breast cancer therapies to reduce mortality and improve quality of life: San Antonio Breast Cancer Symposium 2017 (part 2).针对降低死亡率和提高生活质量的乳腺癌治疗策略：2017 年圣安东尼奥乳腺癌研讨会（第 2 部分）。
Future Oncol. 2018 Aug;14(19):1893-1896. doi: 10.2217/fon-2018-0184. Epub 2018 Jul 18.
6
Tailoring breast cancer therapies to reduce mortality and improve quality of life: San Antonio Breast Cancer Symposium 2017 (part 1).根据个体化差异制定乳腺癌治疗方案以降低死亡率和提高生活质量：2017 年圣安东尼奥乳腺癌研讨会（第 1 部分）。
Future Oncol. 2018 Aug;14(19):1889-1892. doi: 10.2217/fon-2018-0185. Epub 2018 Jul 18.
7
A systematic review of axillary nodal irradiation for the management of the axilla in patients with early-stage breast cancer.早期乳腺癌患者腋窝淋巴结照射治疗的系统评价。
Surg Oncol. 2022 Jun;42:101754. doi: 10.1016/j.suronc.2022.101754. Epub 2022 May 2.
8
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.前哨淋巴结活检与腋窝淋巴结清扫术在接受乳腺癌改良根治术且有 1-2 枚前哨淋巴结转移的患者中的应用：SINODAR-ONE 多中心随机临床试验的亚组分析及再次入组
Br J Surg. 2023 Aug 11;110(9):1143-1152. doi: 10.1093/bjs/znad215.
9
[San Antonio Breast Cancer Symposium 2011 (SABCS): what place will remain to the axillary dissection?].[2011年圣安东尼奥乳腺癌研讨会（SABCS）：腋窝淋巴结清扫术将处于何种地位？]
Gynecol Obstet Fertil. 2012 Apr;40(4):201-3. doi: 10.1016/j.gyobfe.2012.02.019. Epub 2012 Mar 29.
10
Highlights of the San Antonio Breast Cancer Symposium 2016: Part 2.圣安东尼奥乳腺癌研讨会 2016 年要点：第 2 部分。
Future Oncol. 2017 Jul;13(16):1365-1369. doi: 10.2217/fon-2017-0089. Epub 2017 Jul 7.
本文引用的文献
1
Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Metastases.省略腋窝清扫术治疗前哨淋巴结转移乳腺癌。
N Engl J Med. 2024 Apr 4;390(13):1163-1175. doi: 10.1056/NEJMoa2313487.
2
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.前哨淋巴结活检与腋窝淋巴结清扫术在接受乳腺癌改良根治术且有 1-2 枚前哨淋巴结转移的患者中的应用：SINODAR-ONE 多中心随机临床试验的亚组分析及再次入组
Br J Surg. 2023 Aug 11;110(9):1143-1152. doi: 10.1093/bjs/znad215.
3
POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes.POSNOC-POsitive Sentinel NOde：辅助治疗单独与辅助治疗加清除或腋窝放疗的对比：一项在早期乳腺癌且一个或两个前哨淋巴结有转移的女性中进行的腋窝治疗的随机对照试验。
BMJ Open. 2021 Dec 2;11(12):e054365. doi: 10.1136/bmjopen-2021-054365.
4
Clinical Trials for the Surgical Oncologist: Opportunities and Hurdles.外科肿瘤学家的临床试验：机遇与挑战。
Ann Surg Oncol. 2020 Jul;27(7):2269-2275. doi: 10.1245/s10434-020-08472-z. Epub 2020 Apr 21.
5
Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer.新辅助化疗后乳腺癌腋窝残留淋巴结微转移和孤立肿瘤细胞的预后意义。
Ann Surg Oncol. 2019 Oct;26(11):3502-3509. doi: 10.1245/s10434-019-07517-2. Epub 2019 Jun 21.
6
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.腋窝清扫与未清扫对乳腺癌伴前哨淋巴结微转移患者的影响（IBCSG 23-01）：一项随机、对照、3 期临床试验的 10 年随访结果。
Lancet Oncol. 2018 Oct;19(10):1385-1393. doi: 10.1016/S1470-2045(18)30380-2. Epub 2018 Sep 5.
7
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.腋窝淋巴结清扫术与非腋窝淋巴结清扫术对浸润性乳腺癌伴前哨淋巴结转移女性患者10年总生存率的影响：美国外科医师学会肿瘤学组Z0011（联盟）随机临床试验
JAMA. 2017 Sep 12;318(10):918-926. doi: 10.1001/jama.2017.11470.
8
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.乳腺癌前哨淋巴结阳性后腋窝的放疗或手术（EORTC 10981-22023 AMAROS）：一项随机、多中心、开放标签的3期非劣效性试验。
Lancet Oncol. 2014 Nov;15(12):1303-10. doi: 10.1016/S1470-2045(14)70460-7. Epub 2014 Oct 15.
9
Predictors of outcome of mammography in the National Health Service Breast Screening Programme.英国国家医疗服务体系乳腺筛查项目中乳房X光检查结果的预测因素。
J Med Screen. 2002;9(2):74-82. doi: 10.1136/jms.9.2.74.
Zotero 插件